#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Sickle cell anaemia Small intestine adenocarcinoma Retinopathy of prematurity Penile squamous cell carcinoma Neuroendocrine cell hyperplasia of infancy Essential thrombocythaemia Giant cell tumour of tendon sheath Cervix carcinoma recurrent Kawasaki's disease Neuroblastoma recurrent Chronic inflammatory demyelinating polyradiculoneuropathy Retinoblastoma Transitional cell carcinoma Metastases to peritoneum More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis Alexander disease – Treatment Breast angiosarcoma metastatic – Diagnostics Synovial sarcoma metastatic – Basic Information Glomerulonephritis rapidly progressive – Diagnostics Osteosarcoma recurrent – Treatment Propionic acidaemia – Diagnostics Noonan syndrome – Life with Disease Anaplastic thyroid cancer – Diagnostics Chronic granulomatous disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trospium Chloride Ruxolitinib NIZUBAGLUSTAT Immunglobulin PAPAVERINE HYDROCHLORIDE SURVODUTIDE Belumosudil Mesilate ALE.P03 MALIC ACID Redasemtide Naloxegol Oxalate Corylus Avellana L. Stro-002 Glycerol Phenylbutyrate AMG 732 Cefuroxime Sodium Elafibranor For-6219 Depemokimab Heparin More therapies…

    Learn about Your Condition

    Post-acute COVID-19 syndrome Anaemia of chronic disease Prostate cancer recurrent Myocarditis post infection Neoplasm malignant Endometrial cancer stage I Hypoaesthesia Familial hypertriglyceridaemia Sarcoidosis Stem cell transplant Glioblastoma Cerebrovascular accident Asthmatic crisis Spinal osteoarthritis Addison's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Indapamide
    • Ramipril
    Czechia

  • A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Dysmenorrhoea
    • Pain
    Investigated Drugs:
    • Heparin Sodium
    • Celecoxib
    Czechia

  • Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia France Germany +7

  • A study of the effects of nirmatrelvir, ritonavir, and rosuvastatin in healthy adult participants

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Ritonavir
    • Rosuvastatin Calcium
    • Nirmatrelvir
    Belgium

  • Effect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Ethinylestradiol
    • Iclepertin
    • Levonorgestrel
    Germany

  • Effect of itraconazole on the pharmacokinetics of BI 1584862 in healthy male volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Itraconazole
    Germany
Previous Page
1 … 918 919 920 921 922 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!